Page last updated: 2024-10-20

pyrazinamide and Shock

pyrazinamide has been researched along with Shock in 1 studies

pyrazinecarboxamide : A monocarboxylic acid amide resulting from the formal condensation of the carboxy group of pyrazinoic acid (pyrazine-2-carboxylic acid) with ammonia. A prodrug for pyrazinoic acid, pyrazinecarboxamide is used as part of multidrug regimens for the treatment of tuberculosis.

Shock: A pathological condition manifested by failure to perfuse or oxygenate vital organs.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gomi, J1
Aoyagi, T1

Other Studies

1 other study available for pyrazinamide and Shock

ArticleYear
Therapeutic effects and side effects of rifampicin administered daily or twice-weekly.
    Scandinavian journal of respiratory diseases. Supplementum, 1973, Volume: 84

    Topics: Adult; Body Weight; Drug Therapy, Combination; Ethambutol; Exanthema; Female; Fever; Follow-Up Studi

1973